Regulon

Regulon: R-1902

Regulons are regulatory units consisting of a coherently expressed set of genes and the associated regulator(s) whose binding site(s) they share.

Regulon Summary

Regulon summary table displays all associated information related to the specific regulon including the number of genes in the regulon, Hazard ratio, its Regulator, the Transcriptional Program that includes the regulon, Drugs that are associated with members of the regulon, together with mechanism of action and class, and enriched hallmarks of cancer if any.

GenesCox Hazard RatioRegulatorsCausal FlowsTranscriptional ProgramsHallmarks
222.21657121Pr-7Self sufficiency in growth signalInsensitivity to antigrowth signalEvading apoptosisSustained angiogenesisTissue invasion and metastasisTumor-promoting inflammationReprogramming energy metabolismEvading immune detectionLimitless replicative potentialGenome instability and mutation

Regulon Genes

List of genes that are included in the regulon. These genes have similar expression profiles in subset of patients and they share common binding motif for the Regulator of the regulon. Clicking on the gene name will take you to the gene specific page with more details. Please wait while information is collated from several resources after you click.

Entrez IDEnsEMBL IDPreferred NameUniprot ID
51338 ENSG00000110079 MS4A4A Q96JQ5
3587 ENSG00000110324 IL10RA Q13651
397 ENSG00000111348 ARHGDIB P52566
241 ENSG00000132965 ALOX5AP P20292
55303 ENSG00000133574 GIMAP4 A0A090N7X0
272 ENSG00000133805 AMPD3 Q01432
1794 ENSG00000134516 DOCK2 Q92608
283537 ENSG00000139508 SLC46A3 Q7Z3Q1
963 ENSG00000143119 CD53 P19397
2207 ENSG00000158869 FCER1G P30273
3689 ENSG00000160255 ITGB2 D3DSM0
7805 ENSG00000162511 LAPTM5 Q13571
1520 ENSG00000163131 CTSS A0A7P0TB77
6850 ENSG00000165025 SYK P43405
929 ENSG00000170458 CD14 P08571
719 ENSG00000171860 C3AR1 Q16581
4094 ENSG00000178573 MAF O75444
115207 ENSG00000178695 KCTD12 Q96CX2
3059 ENSG00000180353 HCLS1 P14317
51284 ENSG00000196664 TLR7 Q9NYK1
5788 ENSG00000262418 PTPRC P08575
3903 ENSG00000278154 LAIR1 Q6GTX8

Regulon Drugs

NameApproved SymbolTypeAction TypeMechanism of ActionMax Trial PhaseMax GBM Phase
FOSTAMATINIB DISODIUMSYKSmall moleculeINHIBITORTyrosine-protein kinase SYK inhibitor40
FIBOFLAPON SODIUMALOX5APSmall moleculeINHIBITOR5-lipoxygenase activating protein inhibitor30
HYDROXYCHLOROQUINETLR7Small moleculeANTAGONISTToll-like receptor 7 antagonist42
R-343SYKSmall moleculeINHIBITORTyrosine-protein kinase SYK inhibitor20
AME-133VITGB2AntibodyINHIBITORIntegrin beta-2 inhibitor20
R-348SYKSmall moleculeINHIBITORTyrosine-protein kinase SYK inhibitor20
CERDULATINIBJAK1Small moleculeINHIBITORTyrosine-protein kinase JAK1 inhibitor20
VESATOLIMODTLR7Small moleculeACTIVATORToll-like receptor 7 activator20
AZD-8848TLR7Small moleculeAGONISTToll-like receptor 7 agonist20
EFALIZUMABITGALAntibodyINHIBITORIntegrin alpha-L/beta-2 (LFA-1) inhibitor40
HMPL-523SYKSmall moleculeINHIBITORTyrosine-protein kinase SYK inhibitor10
HYDROXYCHLOROQUINE SULFATETLR7Small moleculeANTAGONISTToll-like receptor 7 antagonist40
PETESICATIBCTSSSmall moleculeINHIBITORCathepsin S inhibitor20
ENTOSPLETINIBSYKSmall moleculeINHIBITORTyrosine-protein kinase SYK inhibitor20
CPG-52852TLR7Small moleculeAGONISTToll-like receptor 7 agonist20
R-333SYKSmall moleculeINHIBITORTyrosine-protein kinase SYK inhibitor20
IMIQUIMODTLR7Small moleculeAGONISTToll-like receptor 7 agonist41
IC14CD14AntibodyINHIBITORMonocyte differentiation antigen CD14 inhibitor20
GUSACITINIBSYKSmall moleculeINHIBITORJanus Kinase (JAK) inhibitor20
LIFITEGRASTITGALSmall moleculeANTAGONISTIntegrin alpha-L/beta-2 (LFA-1) antagonist40
VB-201CD14Small moleculeINHIBITORToll-like receptor 2 inhibitor20
GSK-2245035TLR7Small moleculeAGONISTToll-like receptor 7 agonist20
MIVAVOTINIB CITRATESYKSmall moleculeINHIBITORTyrosine-protein kinase SYK inhibitor20
VELIFLAPONALOX5APSmall moleculeINHIBITOR5-lipoxygenase activating protein inhibitor30
TELRATOLIMODTLR8Small moleculeAGONISTToll-like receptor 8 agonist10
FOSTAMATINIBSYKSmall moleculeINHIBITORTyrosine-protein kinase SYK inhibitor40
LANRAPLENIBSYKSmall moleculeINHIBITORTyrosine-protein kinase SYK inhibitor20
MIVAVOTINIBSYKSmall moleculeINHIBITORTyrosine-protein kinase SYK inhibitor20
FIBOFLAPONALOX5APSmall moleculeINHIBITOR5-lipoxygenase activating protein inhibitor30

Causal Flows

Causal Flows are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators and regulons. In the causal flow a mutation may causally activates or deactivates a downstream regulator which then might up- or down-regulates a regulon that contains genes with similar expression profiles and binding sites.

Causal Mechanistic Flows for Regulon R-1902

IDMutationRoleRegulatorRoleRegulon# downstream regulons# diffexp regulonsDrugs
CMF-00738DNAH5up-regulatesMAFBactivatesR-1902252Drugs (29)
CMF-01049ZNF292down-regulatesMAFBactivatesR-19022510Drugs (29)
CMF-01168SKAP2up-regulatesMAFBactivatesR-1902252Drugs (29)
CMF-01603MCM6up-regulatesMAFBactivatesR-1902257Drugs (29)
CMF-02684SLC9A10down-regulatesMAFBactivatesR-1902253Drugs (29)
CMF-10021ATP8A2down-regulatesMAFBactivatesR-19022510Drugs (29)
CMF-10877SMARCA2up-regulatesMAFBactivatesR-1902253Drugs (29)
CMF-11400CYP4F22up-regulatesMAFBactivatesR-1902256Drugs (29)
CMF-14608C1orf177up-regulatesMAFBactivatesR-1902251Drugs (29)
CMF-16017NFIXup-regulatesMAFBactivatesR-1902259Drugs (29)
CMF-17938PRPF40Bdown-regulatesMAFBactivatesR-19022510Drugs (29)
CMF-19634RPSAP58up-regulatesMAFBactivatesR-1902258Drugs (29)
CMF-19690UGT2B4up-regulatesMAFBactivatesR-1902254Drugs (29)
CMF-20102TDRD9up-regulatesMAFBactivatesR-1902257Drugs (29)
CMF-21589MUC17up-regulatesMAFBactivatesR-19022511Drugs (29)
CMF-24304SMCHD1up-regulatesMAFBactivatesR-1902256Drugs (29)
CMF-24848NSUN5down-regulatesMAFBactivatesR-1902255Drugs (29)
CMF-27289CHD5up-regulatesMAFBactivatesR-1902258Drugs (29)
CMF-27578ANKRD36up-regulatesMAFBactivatesR-19022510Drugs (29)
CMF-30507JHDM1Ddown-regulatesMAFBactivatesR-1902256Drugs (29)
CMF-31089LRFN2down-regulatesMAFBactivatesR-1902254Drugs (29)